BPA Call HT001415A0010-0004
Award Date 6/16/15
Potential Completion Date 9/30/15
Potential Value $650K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $3,330,384.44, is for the provision of reagents and peripherals with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating Roche Diagnostics competed openly in the...
- This federal contract award was issued by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and laboratory equipment. The $2,800,000.00 Blanket Purchase Agreement (BPA) Call contract is for the provision of reagents and peripheral consumables. The contract is not designated as a set-aside. Roche Diagnostics holds multiple Indefinite Delivery Vehicles (IDVs) and BPAs with federal agencies such as...
- The Defense Health Agency awarded Roche Diagnostics Corporation a $345,000 firm fixed price Blanket Purchase Agreement (BPA) call for immunology and clinical testing reagents, kits, and consumables on September 21, 2025. The contract is set to be completed by September 30, 2025, with the place of performance in Castleton, Indiana. As a child contract under a larger vehicle, this BPA call represents a task order against pre-negotiated terms and pricing, enabling the DHA to procure diagnostic...
- Roche Diagnostics Corporation has been awarded a $225,869.71 firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency to provide reagents and consumables. The contract has a period of performance through February 17, 2023. As the prime contractor, Roche Diagnostics will deliver the requested laboratory supplies to support the Defense Health Agency's medical research and healthcare programs. No subcontractors or set-aside designations were identified for this...
- This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, with a ceiling value of $302,000.00, is a Blanket Purchase Agreement (BPA) Call placed by the Defense Health Agency (DHA) for the procurement of REAGENTS AND CONSUMABLES. This BPA is part of a larger Indefinite Delivery Contract vehicle held by Roche Diagnostics to provide chemistry reagents...
- Roche Diagnostics Corporation has been awarded a $157,290 firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency to provide reagents and consumables. The contract runs from September 29, 2022 through September 30, 2022 and has no set-aside designation. As part of its mission to support the medical readiness of armed forces personnel, the Defense Health Agency requires diagnostic supplies and materials to conduct laboratory testing and analysis. This BPA call...
- This federal contract award to Roche Diagnostics Corporation is for the provision of reagents and consumables. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type and a ceiling value of $2,250,426.75. The award was made by the Defense Health Agency (DHA), a defense agency, with a period of performance ending on October 5, 2016. This contract does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro...
- The Defense Health Agency has awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation, a global manufacturer of in vitro diagnostic products and laboratory equipment, for the provision of reagents and consumables. This contract is a child award under the VA Schedule V797P-7347A and carries a ceiling value of $288,642.16 under firm fixed-price terms. The award was made on April 30, 2025, with an ultimate completion date of May 2, 2025, and no set-aside designation was...
- <p>The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $500,000 Blanket Purchase Agreement (BPA) Call contract to provide Roche reagents. The contract has a place of performance in Bethesda, Maryland and runs from December 21, 2021 through December 22, 2022 with a Firm Fixed Price pricing structure. Roche Diagnostics Corporation will serve as the prime contractor to supply reagents to the Defense Health Agency, supporting its medical testing needs.</p>
- The U.S. Defense Health Agency awarded Roche Diagnostics Corporation a Blanket Purchase Agreement (BPA) call valued at $2,515,000.00 for the provision of reagents and consumables. This is not a set-aside contract. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various federal agencies, including the Department of Veterans Affairs, Department of...